Researchers analyzed how substance use disorder affected the risk of hospitalization, complications and mortality among adult patients who were diagnosed with having a COVID-19 infection.
Heavy alcohol consumption among adults with a history of binge drinking increases the longer they spend at home in lockdown during the COVID-19 pandemic.
Researchers compared the rate at which patients diagnosed with both depression and a substance use disorder received acute and continuous pharmacotherapy and psychotherapy with the rate at which patients solely diagnosed with depression received the same treatments.
Researchers sought to identify the associations between loneliness, social isolation, and substance use disorder following the ideology of the psychoneuroimmunology paradigm.
Substance use disorder is associated with a higher risk for COVID-19 than that seen in the general population, as well as worse outcomes.
Researchers used data from the National Health and Nutrition Examination Survey 2009-2018 to assess the impact of drug and alcohol use on cardiometabolic disease risk factors.
The 10-item progress assessment tool represents a pragmatic approach to ongoing monitoring in substance use disorders.
Policy changes have occurred alongside the proliferation of high potency cannabis, which may lead to more memory issues or psychotic effects.
The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
The FDA has opened a docket to gather information from the public on the use of vaping products that may be linked to recent lung injuries associated with e-cigarettes.
